Cargando…
GSK-3β Contributes to Parkinsonian Dopaminergic Neuron Death: Evidence From Conditional Knockout Mice and Tideglusib
Glycogen synthase kinase-3 (GSK-3) dysregulation has been implicated in nigral dopaminergic neurodegeneration, one of the main pathological features of Parkinson’s disease (PD). The two isoforms, GSK-3α and GSK-3β, have both been suggested to play a detrimental role in neuronal death. To date, sever...
Autores principales: | Li, Junyu, Ma, Shanshan, Chen, Jingnan, Hu, Kunhua, Li, Yongyi, Zhang, Zeyu, Su, Zixiang, Woodgett, James R., Li, Mingtao, Huang, Qiaoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283909/ https://www.ncbi.nlm.nih.gov/pubmed/32581704 http://dx.doi.org/10.3389/fnmol.2020.00081 |
Ejemplares similares
-
TFE3-Mediated Autophagy is Involved in Dopaminergic Neurodegeneration in Parkinson’s Disease
por: He, Xin, et al.
Publicado: (2021) -
Tideglusib, a prospective alternative to nonoxynol-9 contraceptive
por: Chen, Zhiting, et al.
Publicado: (2019) -
Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson’s disease
por: Chen, Weizhao, et al.
Publicado: (2022) -
Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis
por: Martínez-González, Loreto, et al.
Publicado: (2021) -
CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes
por: Zhang, Wenlong, et al.
Publicado: (2020)